These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31126058)

  • 1. Preliminary Work Towards Finding Proteins as Potential Vaccine Candidates for
    Zeb S; Ali A; Gulfam SM; Bokhari H
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31126058
    [No Abstract]   [Full Text] [Related]  

  • 2. VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.
    Rizwan M; Naz A; Ahmad J; Naz K; Obaid A; Parveen T; Ahsan M; Ali A
    BMC Bioinformatics; 2017 Feb; 18(1):106. PubMed ID: 28193166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds.
    Barh D; Barve N; Gupta K; Chandra S; Jain N; Tiwari S; Leon-Sicairos N; Canizalez-Roman A; dos Santos AR; Hassan SS; Almeida S; Ramos RT; de Abreu VA; Carneiro AR; Soares Sde C; Castro TL; Miyoshi A; Silva A; Kumar A; Misra AN; Blum K; Braverman ER; Azevedo V
    PLoS One; 2013; 8(1):e52773. PubMed ID: 23382822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fishing for vaccines against
    Rashid MI; Rehman S; Ali A; Andleeb S
    PeerJ; 2019; 7():e6223. PubMed ID: 31249730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative core/pan genome analysis of Vibrio cholerae isolates from Pakistan.
    Zeb S; Gulfam SM; Bokhari H
    Infect Genet Evol; 2020 Aug; 82():104316. PubMed ID: 32278144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of vaccine targets in pathogens and design of a vaccine using computational approaches.
    Rawal K; Sinha R; Abbasi BA; Chaudhary A; Nath SK; Kumari P; Preeti P; Saraf D; Singh S; Mishra K; Gupta P; Mishra A; Sharma T; Gupta S; Singh P; Sood S; Subramani P; Dubey AK; Strych U; Hotez PJ; Bottazzi ME
    Sci Rep; 2021 Sep; 11(1):17626. PubMed ID: 34475453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Outer Membrane Protein Candidates for Vaccine Development Against the Pathogen Vibrio anguillarum: A Reverse Vaccinology Based Identification.
    Baliga P; Shekar M; Venugopal MN
    Curr Microbiol; 2018 Mar; 75(3):368-377. PubMed ID: 29119233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
    Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
    Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic plasticity associated with antimicrobial resistance in
    Verma J; Bag S; Saha B; Kumar P; Ghosh TS; Dayal M; Senapati T; Mehra S; Dey P; Desigamani A; Kumar D; Rana P; Kumar B; Maiti TK; Sharma NC; Bhadra RK; Mutreja A; Nair GB; Ramamurthy T; Das B
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6226-6231. PubMed ID: 30867296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Strategy for the Rapid Development of a Safe
    Karpov DS; Goncharenko AV; Usachev EV; Vasina DV; Divisenko EV; Chalenko YM; Pochtovyi AA; Ovchinnikov RS; Makarov VV; Yudin SM; Tkachuk AP; Gushchin VA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Concepts in Cholera Vaccine Design.
    Sit B; Fakoya B; Waldor MK
    Annu Rev Microbiol; 2022 Sep; 76():681-702. PubMed ID: 35759873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates.
    D'Mello A; Ahearn CP; Murphy TF; Tettelin H
    BMC Genomics; 2019 Dec; 20(1):981. PubMed ID: 31842745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection.
    Oladipo EK; Akindiya OE; Oluwasanya GJ; Akanbi GM; Olufemi SE; Adediran DA; Bamigboye FO; Aremu RO; Kolapo KT; Oluwasegun JA; Awobiyi HO; Jimah EM; Irewolede BA; Folakanmi EO; Olubodun OA; Akintibubo SA; Odunlami FD; Ojo TO; Akinro OP; Hezikiah OS; Olayinka AT; Abiala GA; Idowu AF; Ogunniran JA; Ikuomola MO; Adegoke HM; Idowu UA; Olaniyan OP; Bamigboye OO; Akinde SB; Babalola MO
    Immunogenetics; 2023 Apr; 75(2):99-114. PubMed ID: 36459183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.
    Studer E; Candrian U
    Biologicals; 2000 Sep; 28(3):149-54. PubMed ID: 10964441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.
    Kaper JB; Lockman H; Baldini MM; Levine MM
    Nature; 1984 Apr 12-18; 308(5960):655-8. PubMed ID: 6324005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.